Neurohormonal Regulation of IKs in Heart Failure: Implications for Ventricular Arrhythmogenesis and Sudden Cardiac

Tyler Shugg1, Andy Hudmon2, Brian R Overholser1,3

  • 1Division of Clinical Pharmacology Indiana University School of Medicine Indianapolis IN.

Insights

Heart failure (HF) alters neurohormonal signaling, affecting cardiac ion channels and increasing arrhythmia risk. This review details how sympathetic nervous system and renin-angiotensin-aldosterone system pathways regulate potassium currents in HF.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Molecular Biology

Background:

  • Heart failure (HF) involves neurohormonal imbalances, notably sympathetic nervous system (SNS) and renin-angiotensin-aldosterone system (RAAS) activation.
  • Sustained SNS and RAAS activity contribute to HF pathophysiology and increased risk of sudden cardiac death.
  • Cardiac electrical remodeling, including altered ventricular ion channel function, underlies HF-associated arrhythmias.

Purpose of the Study:

  • To review the regulation of the slow component of the delayed rectifier potassium current (IKs) in the context of HF.
  • To elucidate the mechanisms by which HF-associated stimuli impact IKs.
  • To summarize intracellular pathways involved in IKs regulation during heart failure.

Main Methods:

  • Literature review of studies investigating HF-associated stimuli on IKs.
  • Analysis of research on SNS and RAAS signaling in HF.
  • Examination of ion channel regulation and cardiac electrical remodeling.

Main Results:

  • HF stimuli, including SNS and RAAS activation, modulate IKs.
  • Pathological regulation of IKs contributes to action potential duration prolongation and arrhythmogenesis in HF.
  • Specific intracellular signaling cascades mediate these regulatory effects.

Conclusions:

  • Understanding IKs regulation in HF is crucial for explaining arrhythmia development.
  • Targeting IKs pathways may offer therapeutic strategies for HF-related arrhythmias.
  • Further research is needed to fully delineate the complex interplay between HF stimuli and cardiac ion channels.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
743
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
523
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.5K
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
3.5K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.0K